Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study [Peripheral Vascular Disease]

Conclusions— DA+DCB treatment was effective and safe, but the study was not powered to show significant differences between the 2 methods of revascularization in 1-year follow-up. An adequately powered randomized trial is warranted. Clinical Trial Registration— http://www.clinicaltrials.gov. Unique Identifier: NCT01366482.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Tags: Revascularization, Quality and Outcomes, Peripheral Vascular Disease, Stenosis, Vascular Disease Source Type: research